1. Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab). Issue 2 (June 2014) Authors: Biessels, G.J.; Bril, V.; Calcutt, N.A.; Cameron, N.E.; Cotter, M.A.; Dobrowsky, R.; Feldman, E.L.; Fernyhough, P.; Jakobsen, J.; Malik, R.A.; Mizisin, A.P.; Oates, P.J.; Obrosova, I.G.; Pop‐Busui, R.; Russell, J.W.; Sima, A.A.; Stevens, M.J.; Schmidt, R.E.; Tesfaye, S.; Veves, A. Journal: Journal of the peripheral nervous system Issue: Volume 19:Issue 2(2014) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Patient‐reported outcomes with subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: the PATH study. (23rd September 2019) Authors: Hartung, H.‐P.; Mallick, R.; Bril, V.; Lewis, R. A.; Sobue, G.; Lawo, J.‐P.; Mielke, O.; Durn, B. L.; Cornblath, D. R.; Merkies, I. S. J.; van Schaik, I. N. Journal: European journal of neurology Issue: Volume 27:Number 1(2020) Page Start: 196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Chronic stress, depression and personality type in patients with myasthenia gravis. (5th September 2019) Authors: Bogdan, A.; Barnett, C.; Ali, A.; AlQwaifly, M.; Abraham, A.; Mannan, S.; Ng, E.; Bril, V. Journal: European journal of neurology Issue: Volume 27:Number 1(2020) Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 20. Practical application of subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy – results from a multicenter, randomized, double-blind, placebo-controlled trial (The PATH Study). Issue 3 (March 2020) Authors: Schaik, I.N.; Bril, V.; Geloven, N.; Hartung, H.P.; Lewis, R.A.; Sobue, G.; Lawo, J.P.; Mielke, O.; Durn, B.L.; Cornblath, D.R.; Merkies, I.S.J.; Dimachkie, M.M. Journal: Clinical neurophysiology Issue: Volume 131:Issue 3(2020:Mar.) Page Start: e9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 1 (January 2018) Authors: van Schaik, Ivo N; Bril, Vera; van Geloven, Nan; Hartung, Hans-Peter; Lewis, Richard A; Sobue, Gen; Lawo, John-Philip; Praus, Michaela; Mielke, Orell; Durn, Billie L; Cornblath, David R; Merkies, Ingemar S J; Sabet, A.; George, K.; Roberts, L.; Carne, R.; Blum, S.; Henderson, R.; Van Damme, P.; D... Journal: Lancet neurology Issue: Volume 17:Issue 1(2018) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Toronto Clinical Neuropathy Score is valid for a wide spectrum of polyneuropathies. (26th December 2017) Authors: Abraham, A.; Barnett, C.; Katzberg, H. D.; Lovblom, L. E.; Perkins, B. A.; Bril, V. Journal: European journal of neurology Issue: Volume 25:Number 3(2018) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Chronic immunoglobulin maintenance therapy in myasthenia gravis. (15th October 2020) Authors: Alcantara, M.; Sarpong, E.; Barnett, C.; Katzberg, H.; Bril, V. Journal: European journal of neurology Issue: Volume 28:Number 2(2021) Page Start: 639 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Comparison of the single simple question and the patient acceptable symptom state in myasthenia gravis. (16th July 2020) Authors: Menon, D.; Barnett, C.; Bril, V. Journal: European journal of neurology Issue: Volume 27:Number 11(2020) Page Start: 2286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. EQ‐5D‐5L and SF‐6D health utility index scores in patients with myasthenia gravis. (16th November 2018) Authors: Barnett, C.; Bril, V.; Bayoumi, A. M. Journal: European journal of neurology Issue: Volume 26:Number 3(2019) Page Start: 452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Subcutaneous immunoglobulin (SCIG) for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: The PATH Study. Issue 1 (January 2019) Authors: Cocito, D.; Peci, E.; Lauria Pinter, G.; Dacci, P.; Di Muzio, A.; Telese, R.; Schenone, A.; Benedetti, L.; Antonini, G.; Morino, S.; Sorbi, S.; Matà, S.; Bril, V.; van Geloven, N.; Hartung, H.-P.; Lewis, R.A.; Sobue, G.; Lawo, J.-P.; Mielke, O.; Durn, B.L. Journal: Clinical neurophysiology Issue: Volume 130:Issue 1(2019:Jan.) Page Start: e10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗